|
Dimethyl Sulfoxide Gel
» Dimethyl Sulfoxide Gel contains not less than 90.0 percent and not more than 110.0 percent of the labeled concentration of C2H6OS.
Packaging and storage
Preserve in tight, light-resistant containers.
Labeling
Label it to indicate that it is for veterinary use only.
Identification
The retention time of the dimethyl sulfoxide peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Minimum fill
pH
Assay
Internal standard solution
Transfer 1.0 mL of dimethylformamide to a 100-mL volumetric flask. Add about 75 mL of methanol, and shake for about 1 minute. Dilute with methanol to volume, and mix.
Standard preparation
Transfer about 2 g of USP Dimethyl Sulfoxide RS, accurately weighed, to a 100-mL volumetric flask, add 1.0 mL of dimethylformamide and 75 mL of methanol, and shake for about 1 minute. Dilute with methanol to volume, and mix. This solution contains about 20 mg of USP Dimethyl Sulfoxide RS per mL.
Assay preparation
Transfer an accurately weighed quantity of Gel, equivalent to 2 g of dimethyl sulfoxide, to a 100-mL volumetric flask. Add 1.0 mL of dimethylformamide and about 75 mL of methanol. Dilute with methanol to volume, and mix.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 2 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms for not less than 40 minutes, and measure the peak heights for the dimethylformamide and dimethyl sulfoxide peaks. Calculate the percentage (w/w) of C2H6OS in the portion of Gel taken by the formula:
10(C / W)(RU / RS)
in which C is the concentration, in mg per mL, of USP Dimethyl Sulfoxide RS in the Standard preparation; W is the weight, in g, of Gel taken to prepare the Assay preparation; and RU and RS are the ratios of the dimethyl sulfoxide peak response to the dimethylformamide peak response in the chromatograms obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2926
Pharmacopeial Forum: Volume No. 33(1) Page 52
|